Achieve Life Sciences (ACHV) News Today

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 949,700 shares, a growth of 26.5% from the May 15th total of 750,500 shares. Based on an average trading volume of 116,100 shares, the days-to-cover ratio is currently 8.2 days.

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average of $4.59

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average of $4.54

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Analysts at Zacks Small Cap issued their Q2 2024 earnings per share (EPS) estimates for Achieve Life Sciences in a research report issued to clients and investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten forecasts that

Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Investment analysts at Zacks Small Cap issued their FY2026 earnings per share (EPS) estimates for shares of Achieve Life Sciences in a report issued on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten expects that the biopharmaceu

Oppenheimer decreased their price objective on shares of Achieve Life Sciences from $18.00 to $11.00 and set an "outperform" rating for the company in a report on Monday.

Jonestrading began coverage on shares of Achieve Life Sciences in a research note on Wednesday. They issued a "buy" rating and a $20.00 price target on the stock.

Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving Average of $4.40

Oppenheimer reaffirmed an "outperform" rating and issued a $18.00 price target on shares of Achieve Life Sciences in a report on Monday.

Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average of $4.42

Achieve Life Sciences (NASDAQ:ACHV) will be releasing earnings on Thursday, March 14, Yahoo Finance reports.

Lake Street Capital cut their target price on Achieve Life Sciences from $19.00 to $11.00 and set a "buy" rating on the stock in a research report on Tuesday.